• 
  Pallavi Singh, Pratap Vydyam, Tiffany Fang, Karel Estrada, Luis Miguel Gonzalez, et al.. Insights into the evolution, virulence and speciation of Babesia MO1 and Babesia divergens through multiomics analyses. Emerging microbes & infections, 2024, 13 (1), pp.2386136. ⟨10.1080/22221751.2024.2386136⟩. ⟨hal-04693581⟩
• 
  Jennifer Boisgontier, Kévin Beccaria, Ana Saitovitch, Thomas Blauwblomme, Lelio Guida, et al.. Case Report: Zolpidem’s paradoxical restorative action: A case report of functional brain imaging. Frontiers in Neuroscience, 2023, 17, pp.1127542. ⟨10.3389/fnins.2023.1127542⟩. ⟨hal-04484658⟩
• 
  Takashi Matsuwaki, Kiseko Shionoya, Robert Ihnatko, Anna Eskilsson, Shigeru Kakuta, et al.. Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses. Brain, Behavior, and Immunity, 2017, 66, pp.165-176. ⟨10.1016/j.bbi.2017.06.013⟩. ⟨hal-04692648⟩
• 
  Marie Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, Constance Lamy, Magali Lacroix-Triki, et al.. Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors. British Journal of Cancer, In press, ⟨10.1038/s41416-024-02804-6⟩. ⟨hal-04683939⟩
• 
  Diego Teyssonneau, Charles Dariane, Eric Barret, Jean Baptiste Beauval, Laurent Brureau, et al.. PARP inhibitors in prostate cancers, is it time for combinations?. Therapeutic Advances in Medical Oncology, 2024, 16, pp.17588359241242959. ⟨10.1177/17588359241242959⟩. ⟨hal-04605172⟩
• 
  F. Pommeret, J. Colomba, C. Bigenwald, A. Laparra, S. Bockel, et al.. Bamlanivimab + Etesevimab Therapy Induces SARS-CoV-2 Immune Escape Mutations and Secondary Clinical Deterioration in COVID-19 Patients with B-cell Malignancies. Annals of Oncology, 2021, 32 (11), pp.1445--1447. ⟨10.1016/j.annonc.2021.07.015⟩. ⟨hal-03793520⟩
• 
  Bénédicte Bucher, Mouhamadou Ndim, Ana-Maria Olteanu-Raimond, Juste Raimbault, Julien Perret, et al.. Conceptualising a co-operative building evolution dashboard on city regions over the past decades for densification studies. 27th AGILE Conference on Geographic Information Science, "Geographic Information Science for a Sustainable Future", University of Glasgow, Jun 2024, Glasgow, United Kingdom. ⟨hal-04689290⟩
• 
  Charles Herbaux, Caroline Bret, Emmanuel Bachy, Pierre Bories, Roberta Di Blasi, et al.. Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.. Haematologica, 2024, Haematologica, ⟨10.3324/haematol.2023.284786⟩. ⟨hal-04689105⟩
• 
  Vanessa Gauttier, Sabrina Pengam, Justine Durand, Kevin Biteau, Caroline Mary, et al.. Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance. Journal of Clinical Investigation, 2020, 130 (11), pp.6109-6123. ⟨10.1172/JCI135528⟩. ⟨hal-03001660⟩
• 
  Iléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, Dominique Bluteau, Cécile Tomowiak, et al.. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. Blood, 2015, 6 (125), pp.930-940. ⟨10.1182/blood-2014-06-585513⟩. ⟨hal-01681166⟩

8 583

9 284